McKesson Corporation $MCK Position Trimmed by First Horizon Corp

First Horizon Corp cut its position in shares of McKesson Corporation (NYSE:MCK) by 4.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,646 shares of the company’s stock after selling 710 shares during the quarter. First Horizon Corp’s holdings in McKesson were worth $12,674,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the business. Cullen Investment Group LTD. lifted its holdings in shares of McKesson by 550.4% during the 4th quarter. Cullen Investment Group LTD. now owns 4,670 shares of the company’s stock valued at $3,811,000 after buying an additional 3,952 shares during the last quarter. Pensionfund Sabic acquired a new stake in shares of McKesson in the fourth quarter valued at about $1,887,000. Investment Research Partners LLC acquired a new position in shares of McKesson during the third quarter worth approximately $1,303,000. Achmea Investment Management B.V. raised its stake in McKesson by 7.5% during the 3rd quarter. Achmea Investment Management B.V. now owns 61,287 shares of the company’s stock valued at $47,347,000 after purchasing an additional 4,260 shares during the last quarter. Finally, Horizon Investments LLC grew its holdings in shares of McKesson by 125.4% during the 4th quarter. Horizon Investments LLC now owns 8,679 shares of the company’s stock worth $7,119,000 after purchasing an additional 4,828 shares in the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insider Activity at McKesson

In related news, CEO Brian S. Tyler sold 8,463 shares of the firm’s stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $793.56, for a total value of $6,715,898.28. Following the completion of the sale, the chief executive officer owned 5,919 shares of the company’s stock, valued at $4,697,081.64. This trade represents a 58.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Napoleon B. Rutledge, Jr. sold 133 shares of McKesson stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $764.00, for a total value of $101,612.00. Following the completion of the sale, the chief accounting officer owned 632 shares of the company’s stock, valued at approximately $482,848. The trade was a 17.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 28,748 shares of company stock valued at $22,262,035 over the last three months. 0.06% of the stock is owned by company insiders.

McKesson Stock Down 3.1%

Shares of McKesson stock opened at $793.32 on Friday. The stock has a market capitalization of $92.88 billion, a P/E ratio of 20.62, a price-to-earnings-growth ratio of 1.35 and a beta of 0.31. The company has a 50-day simple moving average of $766.72 and a 200 day simple moving average of $838.77. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00.

McKesson (NYSE:MCK) last announced its earnings results on Thursday, May 7th. The company reported $11.69 EPS for the quarter, topping the consensus estimate of $11.56 by $0.13. The business had revenue of $96.30 billion for the quarter, compared to the consensus estimate of $101.35 billion. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.McKesson’s revenue was up 6.0% compared to the same quarter last year. During the same period in the previous year, the business earned $10.12 EPS. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. On average, equities analysts anticipate that McKesson Corporation will post 44.28 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st were paid a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend was Monday, June 1st. McKesson’s dividend payout ratio is 8.53%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on MCK. Bank of America decreased their price target on shares of McKesson from $1,040.00 to $1,000.00 and set a “buy” rating on the stock in a research note on Monday, April 6th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $875.00 price objective on shares of McKesson in a research note on Friday, May 8th. UBS Group lifted their target price on shares of McKesson from $1,000.00 to $1,050.00 and gave the company a “buy” rating in a research report on Friday, May 8th. William Blair assumed coverage on shares of McKesson in a research note on Tuesday, April 28th. They issued an “outperform” rating on the stock. Finally, Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a research report on Saturday, June 27th. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, McKesson presently has an average rating of “Moderate Buy” and a consensus target price of $960.53.

Key Stories Impacting McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: McKesson’s last earnings report beat adjusted EPS estimates and management reaffirmed FY2027 adjusted EPS guidance of $43.80 to $44.60, which supports the company’s longer-term earnings outlook.
• Positive Sentiment: Analyst sentiment remains generally favorable, with a moderate buy consensus and multiple firms maintaining overweight/buy ratings, suggesting Wall Street still sees upside potential.
• Neutral Sentiment: McKesson recently announced its next earnings date for August 5, so investors are likely in a wait-and-see mode ahead of the next quarterly update.
• Neutral Sentiment: The company also disclosed new debt tied to the planned separation of its Medical-Surgical Solutions business, a move that may improve strategic focus but also keeps attention on execution and balance-sheet changes.
• Negative Sentiment: Investors are still reacting to the prior quarter’s revenue shortfall, which outweighed the EPS beat and has kept sentiment cautious around near-term growth.
• Negative Sentiment: Recent leadership turnover, including the planned retirement of Chief Strategy and Business Development Officer Thomas L. Rodgers and a large CEO stock sale under a 10b5-1 plan, may be adding to concerns about insider confidence and continuity.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.